The duration of clinical remission of photochemotherapy and narrow-band UV-B phototherapy in the treatment of psoriasis: A retrospective study

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 2, 2008, Pages 481-484

  Brazzelli, Valeria ^a   Barbagallo, T ^a   Trevisan, V ^a   Muzio, F ^a   De Silvestri, A ^a   Borroni, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Psoriasis; Puva; Remission; Uvb nb

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; REMISSION; RETROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; ULTRAVIOLET B RADIATION;

EID: 47249153908     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100232     Document Type: Article

References (18)

1. Lebwohl M. Psoriasis. Lancet 2003; 361:1197-204.
2. Lebwohl M., Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol 2001; 45: 649-61.
3. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis. Arch Dermatol 1999; 135: 519-24.
4. Karrer S, Eholzer C, Ackermann G, Landthaler M, Szeimies RM. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches. Dermatol 2001; 202:108-15.
5. Zanolli M. Phototherapy treatment of psoriasis today. J Am Acad Dermatol 2003; 49(2S):78-86.
6. Bandow GD, Koo JYM. Narrow-band ultraviolet B radiation: a review of the current literature. Int J Dermatol 2004; 43(8):555-61.
7. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxalen and long wave ultraviolet light. N Engl J Med 1974; 291:1207-11.
8. Van Weelden H, Baart de la Faille H, Young E, Van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-9.
9. Lebwohl M. A clinician's paradigm in the treatment of psoriasis. J Am Acad Dermatol 2005; 53(1S):59-69.
10. Koo JY, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999; 41: 51-9.
11. Choi J, Koo JY. Quality of life issues in psoriasis. J Am Acad Dermatol 2003; 49(2S):57-61.
12. Mukhtar R, Choi J, Koo JY. Quality-of-life issues in psoriasis. J Am Acad Dermatol 2004; 22:389-95.
13. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994; 73: 2759-64.
14. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrow-band ultraviolet B and broad spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photoderm Photoimmunol Photomed 1994; 10:192-7.
15. Weischer M, Blum A, Eberhard F, Rocken M, Berneburg M. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol 2004; 84:370-4.
16. Van Weelden H, Bart de la Faille H, Young E, Van Der Leun JC. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol 1990; 70: 212-5.
17. Gordon PM, Diffey L, Matthews JNS, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999; 41:728-32.
18. Markham T, Rogers S, Collins P. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol 2003; 139:325-8.